ARVN
Price
$7.55
Change
-$0.35 (-4.43%)
Updated
Sep 4, 01:51 PM (EDT)
Capitalization
580M
68 days until earnings call
COGT
Price
$12.84
Change
-$0.24 (-1.83%)
Updated
Sep 4, 01:57 PM (EDT)
Capitalization
1.83B
74 days until earnings call
Interact to see
Advertisement

ARVN vs COGT

Header iconARVN vs COGT Comparison
Open Charts ARVN vs COGTBanner chart's image
Arvinas
Price$7.55
Change-$0.35 (-4.43%)
Volume$489
Capitalization580M
Cogent Biosciences
Price$12.84
Change-$0.24 (-1.83%)
Volume$957
Capitalization1.83B
ARVN vs COGT Comparison Chart in %
Loading...
ARVN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
COGT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ARVN vs. COGT commentary
Sep 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ARVN is a Hold and COGT is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 04, 2025
Stock price -- (ARVN: $7.90 vs. COGT: $13.08)
Brand notoriety: ARVN and COGT are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ARVN: 54% vs. COGT: 127%
Market capitalization -- ARVN: $580M vs. COGT: $1.83B
ARVN [@Biotechnology] is valued at $580M. COGT’s [@Biotechnology] market capitalization is $1.83B. The market cap for tickers in the [@Biotechnology] industry ranges from $101.69B to $0. The average market capitalization across the [@Biotechnology] industry is $1.88B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ARVN’s FA Score shows that 1 FA rating(s) are green whileCOGT’s FA Score has 0 green FA rating(s).

  • ARVN’s FA Score: 1 green, 4 red.
  • COGT’s FA Score: 0 green, 5 red.
According to our system of comparison, ARVN is a better buy in the long-term than COGT.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ARVN’s TA Score shows that 5 TA indicator(s) are bullish while COGT’s TA Score has 3 bullish TA indicator(s).

  • ARVN’s TA Score: 5 bullish, 5 bearish.
  • COGT’s TA Score: 3 bullish, 4 bearish.
According to our system of comparison, ARVN is a better buy in the short-term than COGT.

Price Growth

ARVN (@Biotechnology) experienced а -2.23% price change this week, while COGT (@Biotechnology) price change was +5.74% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -0.72%. For the same industry, the average monthly price growth was +5.89%, and the average quarterly price growth was +27.72%.

Reported Earning Dates

ARVN is expected to report earnings on Nov 11, 2025.

COGT is expected to report earnings on Nov 17, 2025.

Industries' Descriptions

@Biotechnology (-0.72% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
COGT($1.83B) has a higher market cap than ARVN($580M). COGT YTD gains are higher at: 67.692 vs. ARVN (-58.790). ARVN has higher annual earnings (EBITDA): -112.6M vs. COGT (-299.34M). ARVN has more cash in the bank: 861M vs. COGT (238M). ARVN has less debt than COGT: ARVN (9.9M) vs COGT (60.7M). ARVN has higher revenues than COGT: ARVN (373M) vs COGT (0).
ARVNCOGTARVN / COGT
Capitalization580M1.83B32%
EBITDA-112.6M-299.34M38%
Gain YTD-58.79067.692-87%
P/E RatioN/AN/A-
Revenue373M0-
Total Cash861M238M362%
Total Debt9.9M60.7M16%
FUNDAMENTALS RATINGS
ARVN vs COGT: Fundamental Ratings
ARVN
COGT
OUTLOOK RATING
1..100
1673
VALUATION
overvalued / fair valued / undervalued
1..100
14
Undervalued
87
Overvalued
PROFIT vs RISK RATING
1..100
10085
SMR RATING
1..100
94100
PRICE GROWTH RATING
1..100
6437
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
n/a50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ARVN's Valuation (14) in the Biotechnology industry is significantly better than the same rating for COGT (87) in the Miscellaneous industry. This means that ARVN’s stock grew significantly faster than COGT’s over the last 12 months.

COGT's Profit vs Risk Rating (85) in the Miscellaneous industry is in the same range as ARVN (100) in the Biotechnology industry. This means that COGT’s stock grew similarly to ARVN’s over the last 12 months.

ARVN's SMR Rating (94) in the Biotechnology industry is in the same range as COGT (100) in the Miscellaneous industry. This means that ARVN’s stock grew similarly to COGT’s over the last 12 months.

COGT's Price Growth Rating (37) in the Miscellaneous industry is in the same range as ARVN (64) in the Biotechnology industry. This means that COGT’s stock grew similarly to ARVN’s over the last 12 months.

COGT's P/E Growth Rating (100) in the Miscellaneous industry is in the same range as ARVN (100) in the Biotechnology industry. This means that COGT’s stock grew similarly to ARVN’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ARVNCOGT
RSI
ODDS (%)
Bearish Trend 2 days ago
80%
N/A
Stochastic
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 2 days ago
85%
Momentum
ODDS (%)
Bullish Trend 2 days ago
76%
Bullish Trend 2 days ago
83%
MACD
ODDS (%)
Bullish Trend 2 days ago
74%
Bullish Trend 2 days ago
83%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
77%
Bullish Trend 2 days ago
84%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
73%
Bullish Trend 2 days ago
83%
Advances
ODDS (%)
Bullish Trend 9 days ago
79%
Bullish Trend 9 days ago
83%
Declines
ODDS (%)
Bearish Trend 7 days ago
80%
Bearish Trend 29 days ago
83%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
74%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
79%
View a ticker or compare two or three
Interact to see
Advertisement
ARVN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
COGT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
HLGZX36.720.30
+0.82%
Harding Loevner Global Equity Instl Z
JLCVX75.530.35
+0.47%
JHancock Fundamental Large Cap Core R5
DLQIX16.400.06
+0.37%
BNY Mellon Large Cap Equity I
BKPIX67.020.15
+0.22%
ProFunds Banks UltraSector Inv
PGOFX53.500.01
+0.02%
Victory Pioneer Select Mid Cap Growth A

ARVN and

Correlation & Price change

A.I.dvisor indicates that over the last year, ARVN has been loosely correlated with ERAS. These tickers have moved in lockstep 39% of the time. This A.I.-generated data suggests there is some statistical probability that if ARVN jumps, then ERAS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ARVN
1D Price
Change %
ARVN100%
N/A
ERAS - ARVN
39%
Loosely correlated
-10.63%
GMAB - ARVN
37%
Loosely correlated
+4.60%
TECH - ARVN
37%
Loosely correlated
-0.15%
TRML - ARVN
35%
Loosely correlated
+6.53%
COGT - ARVN
34%
Loosely correlated
+9.00%
More

COGT and

Correlation & Price change

A.I.dvisor indicates that over the last year, COGT has been loosely correlated with HOFBF. These tickers have moved in lockstep 63% of the time. This A.I.-generated data suggests there is some statistical probability that if COGT jumps, then HOFBF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To COGT
1D Price
Change %
COGT100%
+9.00%
HOFBF - COGT
63%
Loosely correlated
N/A
TNFA - COGT
55%
Loosely correlated
-8.42%
CGON - COGT
50%
Loosely correlated
+4.41%
IDYA - COGT
50%
Loosely correlated
+1.10%
ATXS - COGT
50%
Loosely correlated
+6.07%
More